Pages that link to "Q45021791"

The following pages link to Effect of novel alpha-conotoxins on nicotine-stimulated [3H]dopamine release from rat striatal synaptosomes (Q45021791):

Displaying 22 items.

• The neuronal nicotinic acetylcholine receptors alpha 4* and alpha 6* differentially modulate dopamine release in mouse striatal slices (Q24655429) (← links)
• Preclinical evidence that activation of mesolimbic alpha 6 subunit containing nicotinic acetylcholine receptors supports nicotine addiction phenotype (Q27021772) (← links)
• Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse (Q28306056) (← links)
• Stable expression and functional characterization of a human nicotinic acetylcholine receptor with α6β2 properties: discovery of selective antagonists (Q28388268) (← links)
• Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors (Q33621205) (← links)
• A novel α-conotoxin MII-sensitive nicotinic acetylcholine receptor modulates [(3) H]-GABA release in the superficial layers of the mouse superior colliculus (Q33632310) (← links)
• Indolizidine (−)-235B′ and related structural analogs: Discovery of nicotinic receptor antagonists that inhibit nicotine-evoked [3H]dopamine release (Q33836376) (← links)
• Progress and challenges in the study of α6-containing nicotinic acetylcholine receptors (Q33954007) (← links)
• bPiDI: a novel selective α6β2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse (Q34919642) (← links)
• Monkey adrenal chromaffin cells express α6β4* nicotinic acetylcholine receptors (Q35146483) (← links)
• Naturally-expressed nicotinic acetylcholine receptor subtypes (Q35185264) (← links)
• α-Conotoxin BuIA[T5A;P6O]: a novel ligand that discriminates between α6β4 and α6β2 nicotinic acetylcholine receptors and blocks nicotine-stimulated norepinephrine release (Q35588867) (← links)
• Native α6β4* nicotinic receptors control exocytosis in human chromaffin cells of the adrenal gland (Q35648038) (← links)
• Developmental regulation of nicotinic acetylcholine receptors within midbrain dopamine neurons (Q36063653) (← links)
• r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement (Q36266312) (← links)
• Positional scanning mutagenesis of α-conotoxin PeIA identifies critical residues that confer potency and selectivity for α6/α3β2β3 and α3β2 nicotinic acetylcholine receptors (Q37132142) (← links)
• Structural basis for alpha-conotoxin potency and selectivity (Q37369436) (← links)
• Mysterious alpha6-containing nAChRs: function, pharmacology, and pathophysiology (Q37508589) (← links)
• Nicotinic receptor-based therapeutics and candidates for smoking cessation (Q37518024) (← links)
• Diverse strategies targeting α7 homomeric and α6β2* heteromeric nicotinic acetylcholine receptors for smoking cessation (Q38204497) (← links)
• Amino acid residues that confer high selectivity of the alpha6 nicotinic acetylcholine receptor subunit to alpha-conotoxin MII[S4A,E11A,L15A]. (Q38293240) (← links)
• Mice expressing the ADNFLE valine 287 leucine mutation of the Β2 nicotinic acetylcholine receptor subunit display increased sensitivity to acute nicotine administration and altered presynaptic nicotinic receptor function (Q42728501) (← links)